Veloxis Pharmaceuticals A/S Release: Warrant Programme - Registration Of Capital Increase And New Articles Of Association Following Warrant Exercise
With reference to Company Announcement no. 7/2014 of 20 March 2014, Veloxis Pharmaceuticals A/S announces that as a consequence of warrant exercise a capital increase of nominal 195,485.70 new shares with a nominal value of DKK 0.10 each has been registered with the Danish Business Authority today.
Help employers find you! Check out all the jobs and post your resume.